Geode Capital Management, LLC G1 Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

A detailed history of Geode Capital Management, LLC transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,079,645 shares of GTHX stock, worth $7.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,079,645

Previous 505,805 113.45%

Holding current value

$7.72 Million

Previous $2.19 Million 12.63%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$2.2 - $4.98 $1.26 Million - $2.86 Million	573,840 Added 113.45%	1,079,645 $2.46 Million
Q1 2024 May 13, 2024	BUY	$2.1 - $4.83 $94,563 - $217,494	45,030 Added 9.77%	505,805 $2.19 Million
Q4 2023 Feb 13, 2024	BUY	$1.12 - $3.73 $22,559 - $75,129	20,142 Added 4.57%	460,775 $1.41 Million
Q3 2023 Nov 13, 2023	BUY	$1.22 - $2.67 $10,956 - $23,979	8,981 Added 2.08%	440,633 $634,000
Q2 2023 Aug 11, 2023	SELL	$2.46 - $3.14 $16,585 - $21,169	-6,742 Reduced 1.54%	431,652 $1.07 Million
Q1 2023 May 15, 2023	BUY	$2.57 - $8.16 $215,507 - $684,256	83,855 Added 23.65%	438,394 $1.17 Million
Q4 2022 Feb 13, 2023	BUY	$5.19 - $13.5 $37,803 - $98,334	7,284 Added 2.1%	354,539 $1.93 Million
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $27,711 - $91,066	5,360 Added 1.57%	347,255 $4.34 Million
Q2 2022 Aug 12, 2022	SELL	$4.04 - $8.51 $1.32 Million - $2.78 Million	-326,245 Reduced 48.83%	341,895 $1.69 Million
Q1 2022 May 13, 2022	SELL	$7.6 - $11.02 $358,970 - $520,507	-47,233 Reduced 6.6%	668,140 $5.08 Million
Q4 2021 Feb 11, 2022	BUY	$10.16 - $16.17 $734,263 - $1.17 Million	72,270 Added 11.24%	715,373 $7.3 Million
Q3 2021 Nov 12, 2021	BUY	$13.16 - $22.47 $431,371 - $736,544	32,779 Added 5.37%	643,103 $8.63 Million
Q2 2021 Aug 13, 2021	BUY	$19.57 - $26.32 $1.16 Million - $1.56 Million	59,141 Added 10.73%	610,324 $13.4 Million
Q1 2021 May 12, 2021	BUY	$17.58 - $32.59 $1.18 Million - $2.19 Million	67,343 Added 13.92%	551,183 $13.3 Million
Q4 2020 Feb 12, 2021	BUY	$10.99 - $20.4 $194,654 - $361,324	17,712 Added 3.8%	483,840 $8.7 Million
Q3 2020 Nov 13, 2020	SELL	$11.55 - $23.75 $20,709 - $42,583	-1,793 Reduced 0.38%	466,128 $5.38 Million
Q2 2020 Aug 13, 2020	BUY	$9.57 - $24.37 $96,523 - $245,795	10,086 Added 2.2%	467,921 $11.4 Million
Q1 2020 May 14, 2020	BUY	$9.07 - $26.32 $382,119 - $1.11 Million	42,130 Added 10.13%	457,835 $5.05 Million
Q4 2019 Feb 13, 2020	BUY	$20.54 - $31.0 $307,874 - $464,659	14,989 Added 3.74%	415,705 $11 Million
Q3 2019 Nov 12, 2019	BUY	$22.78 - $40.58 $458,242 - $816,307	20,116 Added 5.29%	400,716 $9.13 Million
Q2 2019 Aug 14, 2019	BUY	$16.03 - $31.1 $1.1 Million - $2.13 Million	68,370 Added 21.9%	380,600 $11.7 Million
Q1 2019 May 14, 2019	BUY	$14.4 - $21.45 $477,604 - $711,432	33,167 Added 11.89%	312,230 $5.18 Million
Q4 2018 Feb 13, 2019	BUY	$16.51 - $51.33 $430,877 - $1.34 Million	26,098 Added 10.32%	279,063 $5.34 Million
Q3 2018 Nov 13, 2018	BUY	$43.15 - $67.97 $1.45 Million - $2.28 Million	33,554 Added 15.29%	252,965 $13.2 Million
Q2 2018 Aug 14, 2018	BUY	$35.06 - $51.17 $1.17 Million - $1.71 Million	33,434 Added 17.98%	219,411 $9.54 Million
Q1 2018 May 15, 2018	BUY	$19.05 - $41.76 $1.75 Million - $3.83 Million	91,611 Added 97.08%	185,977 $6.89 Million
Q4 2017 Feb 13, 2018	BUY	$19.01 - $26.2 $153,239 - $211,198	8,061 Added 9.34%	94,366 $1.87 Million
Q3 2017 Nov 14, 2017	BUY	$12.53 - $27.12 $953,345 - $2.06 Million	76,085 Added 744.47%	86,305 $2.15 Million
Q2 2017 Aug 14, 2017	BUY	N/A	10,220	10,220 $178,000

Others Institutions Holding GTHX

# of Institutions

101

Shares Held

20.1M

Call Options Held

1.87M

Put Options Held

1.18M

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC G1 Therapeutics, Inc. Transaction History